{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:08:53Z","timestamp":1790467733853,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.2515\/therapie\/2011046","type":"journal-article","created":{"date-parts":[[2011,8,18]],"date-time":"2011-08-18T12:53:39Z","timestamp":1313672019000},"page":"331-334","source":"Crossref","is-referenced-by-count":6,"title":["How to Improve the Clinical Development Paradigm and its Division into Phases I, II and III"],"prefix":"10.1016","volume":"66","author":[{"given":"Marion","family":"Bamberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Lechat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Blin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Bouhassira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Cellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Demarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Duval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Gueyffier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Le Jeunne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Libersa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Mahlberg-Gaudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Maison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Marquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Molimard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Moser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Pavlovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Piedbois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Regnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Reynier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Rey-Quinio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Rossignol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Spriet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Vignal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2515\/therapie\/2011046_bb0005","article-title":"An adaptive seamless phase II\/III design for oncology trials with subpopulation selection using correlated survival endpointsdagger","author":"Jenkins","year":"2010","journal-title":"Pharm Stat"},{"issue":"5","key":"10.2515\/therapie\/2011046_bb0010","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/1740774510372657","article-title":"A Bayesian adaptive design with biomarkers for targeted therapies","volume":"7","author":"Eickhoff","year":"2010","journal-title":"Clin Trials"},{"issue":"6","key":"10.2515\/therapie\/2011046_bb0015","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1080\/10543406.2010.514447","article-title":"Perspectives on the use of adaptive designs in clinical trials. Part II. Panel discussion","volume":"20","author":"Benda","year":"2010","journal-title":"J Biopharm Stat"},{"issue":"6","key":"10.2515\/therapie\/2011046_bb0020","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1080\/10543406.2010.514453","article-title":"Comments on the draft guidance on \"adaptive design clinical trials for drugs and biologics\" of the U.S. Food and Drug Administration","volume":"20","author":"Brannath","year":"2010","journal-title":"J Biopharm Stat"},{"issue":"6","key":"10.2515\/therapie\/2011046_bb0025","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1080\/10543406.2010.514448","article-title":"Introduction to discussion papers on draft FDA guidance on adaptive designs","volume":"20","author":"Chang","year":"2010","journal-title":"J Biopharm Stat"},{"issue":"6","key":"10.2515\/therapie\/2011046_bb0030","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1080\/10543406.2010.514460","article-title":"On flexibility of adaptive designs and criteria for choosing a good one\u2013a discussion of FDA draft guidance","volume":"20","author":"Cheng","year":"2010","journal-title":"J Biopharm Stat"},{"issue":"6","key":"10.2515\/therapie\/2011046_bb0035","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1080\/10543406.2010.514444","article-title":"A note on special articles on adaptive clinical trial designs","volume":"20","author":"Chow","year":"2010","journal-title":"J Biopharm Stat"},{"issue":"6","key":"10.2515\/therapie\/2011046_bb0040","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1080\/10543406.2010.514456","article-title":"FDA draft guidance on adaptive design clinical trials: Pfizer\u2019s perspective","volume":"20","author":"Chuang-Stein","year":"2010","journal-title":"J Biopharm Stat"},{"issue":"6","key":"10.2515\/therapie\/2011046_bb0045","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1080\/10543406.2010.514455","article-title":"Review of draft FDA adaptive design guidance","volume":"20","author":"Cook","year":"2010","journal-title":"J Biopharm Stat"},{"issue":"6","key":"10.2515\/therapie\/2011046_bb0050","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1080\/10543406.2010.514457","article-title":"Adaptive methods: telling \"the rest of the story\"","volume":"20","author":"Emerson","year":"2010","journal-title":"J Biopharm Stat"},{"issue":"5","key":"10.2515\/therapie\/2011046_bb0055","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1080\/10543400903315740","article-title":"Bayesian adaptive dose-finding studies with delayed responses","volume":"20","author":"Fu","year":"2010","journal-title":"J Biopharm Stat"},{"issue":"6","key":"10.2515\/therapie\/2011046_bb0060","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1080\/10543406.2010.514452","article-title":"Viewpoints on the FDA draft adaptive designs guidance from the PhRMA working group","volume":"20","author":"Gallo","year":"2010","journal-title":"J Biopharm Stat"},{"issue":"6","key":"10.2515\/therapie\/2011046_bb0065","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1080\/10543406.2010.514462","article-title":"Understanding the FDA guidance on adaptive designs: historical, legal, and statistical perspectives","volume":"20","author":"Liu","year":"2010","journal-title":"J Biopharm Stat"},{"issue":"4","key":"10.2515\/therapie\/2011046_bb0070","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1080\/10543401003618066","article-title":"Analysis of time-to-event data under a two-stage survival adaptive design in clinical trials","volume":"20","author":"Lu","year":"2010","journal-title":"J Biopharm Stat"},{"issue":"6","key":"10.2515\/therapie\/2011046_bb0075","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/10543406.2010.514461","article-title":"Editorial. Adaptive designs: appealing in development of therapeutics, and where do controversies lie?","volume":"20","author":"Wang","year":"2010","journal-title":"J Biopharm Stat"},{"issue":"6","key":"10.2515\/therapie\/2011046_bb0080","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1080\/10543406.2010.514446","article-title":"Perspectives on the use of adaptive designs in clinical trials. Part I. Statistical considerations and issues","volume":"20","author":"Wang","year":"2010","journal-title":"J Biopharm Stat"},{"issue":"2","key":"10.2515\/therapie\/2011046_bb0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1472-8206.2009.00746.x","article-title":"Adaptive designs for Phase I dose-finding studies","volume":"24","author":"Zhou","year":"2010","journal-title":"Fundam Clin Pharmacol"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716307818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716307818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,10]],"date-time":"2024-04-10T08:31:31Z","timestamp":1712737891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716307818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0040595716307818"],"URL":"https:\/\/doi.org\/10.2515\/therapie\/2011046","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}